Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Rifaximin for the Treatment of Irritable Bowel Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00259155
Recruitment Status : Completed
First Posted : November 29, 2005
Last Update Posted : March 18, 2008
University of Chicago
Bausch Health Americas, Inc.
Information provided by:
Cedars-Sinai Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2007
Actual Study Completion Date : January 2007